Kentucky bills · 2026 Regular Session
Kentucky SB 77
AN ACT relating to ibogaine research in the Commonwealth.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
No sponsor recorded.
Summary
Official abstract published by the Kentucky legislature· Summary of Original Version
Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.
Text versions
Roll-call votes
State vote data last updated Oct 15, 2026, 12:03 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Apr 14, 2026 Senate | Veto Override | pass | Set your home in Kentucky to see |
| Apr 14, 2026 Senate | OVERRIDE VETO FINAL PASSAGE SB 77 | pass | Set your home in Kentucky to see |
| Apr 1, 2026 Senate | Pass | pass | Set your home in Kentucky to see |
| Mar 13, 2026 Senate | PASS SB 77 w/ SCS 1, SCA 1 (T) | pass | Set your home in Kentucky to see |
Actions
- Apr 14, 2026 · Senate
delivered to Secretary of State (Acts Ch. 158) - Apr 14, 2026 · House
enrolled, signed by Speaker of the House - Apr 14, 2026 · Senate
enrolled, signed by President of the Senate - Apr 14, 2026 · Senate
received in Senate - Apr 14, 2026 · Senate
passed 77-18 - Apr 14, 2026 · Senate
veto overridden - Apr 14, 2026 · Senate
posted for consideration of Governor's veto - Apr 14, 2026 · House
taken from Rules (H) - Apr 14, 2026 · House
to Rules (H) - Apr 14, 2026 · House
received in House - Apr 14, 2026 · Senate
passed 31-6 - Apr 14, 2026 · Senate
veto overridden - Apr 14, 2026 · Senate
posted for passage for consideration of Governor's veto - Apr 14, 2026 · Senate
to Rules (S) - Apr 14, 2026 · Senate
received in Senate - Apr 13, 2026 · Senate
Vetoed - Apr 1, 2026 · Senate
delivered to Governor - Apr 1, 2026 · House
enrolled, signed by Speaker of the House - Apr 1, 2026 · Senate
enrolled, signed by President of the Senate - Apr 1, 2026 · Senate
received in Senate - Apr 1, 2026 · Senate
3rd reading, passed 82-8 - Apr 1, 2026 · Senate
placed in the Orders of the Day - Apr 1, 2026 · Senate
taken from Rules - Mar 25, 2026 · Senate
2nd reading, to Rules - Mar 24, 2026 · Senate
reported favorably, 1st reading, to Calendar - Mar 20, 2026 · House
to Veterans, Military Affairs, & Public Protection (H) - Mar 17, 2026 · House
to Committee on Committees (H) - Mar 17, 2026 · House
received in House - Mar 13, 2026 · Senate
3rd reading, passed 35-2 with Committee Substitute (1) and Committee Amendment (1-title) - Mar 12, 2026 · Senate
posted for passage in the Regular Orders of the Day for Friday, March 13 2026 - Mar 12, 2026 · Senate
2nd reading, to Rules - Mar 11, 2026 · Senate
reported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title) - Mar 9, 2026 · Senate
to Health Services (S) - Jan 13, 2026 · Senate
to Committee on Committees (S) - Jan 13, 2026 · Senate
introduced in Senate